Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-010007
Filing Date
2020-04-02
Accepted
2020-04-02 19:02:45
Documents
2
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4828
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4716
  Complete submission text file 0000899243-20-010007.txt   10885
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35945 | Film No.: 20770980

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Issuer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations